About Millendo Therapeutics
Millendo Therapeutics is a company based in Ann Arbor (United States) founded in 2012.. Millendo Therapeutics has raised $102.77 million across 5 funding rounds from investors including University of Michigan, Frazier Healthcare Partners and NEA. The company has 30 employees as of December 31, 2022. Millendo Therapeutics has completed 1 acquisition, including Alizé Pharma. Millendo Therapeutics operates in a competitive market with competitors including BeiGene, Moderna, Incyte, Regeneron Pharmaceuticals and Mereo BioPharma, among others.
- Headquarter Ann Arbor, United States
- Employees 30 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Atterocor Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$102.77 M (USD)
in 5 rounds
-
Latest Funding Round
$62 M (USD), Series B
Jan 04, 2016
-
Investors
University of Michigan
& 9 more
-
Employee Count
30
as on Dec 31, 2022
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Millendo Therapeutics
Millendo Therapeutics has successfully raised a total of $102.77M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $62 million completed in January 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series B — $62.0M
-
First Round
First Round
(23 Apr 2012)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2016 | Amount | Series B - Millendo Therapeutics | Valuation | New Enterprise Associates | |
| Feb, 2013 | Amount | Private Equity Round - Millendo Therapeutics | Valuation |
investors |
|
| Feb, 2013 | Amount | Series A - Millendo Therapeutics | Valuation | 5AM Ventures , Frazier Healthcare Partners |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Millendo Therapeutics
Millendo Therapeutics has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include University of Michigan, Frazier Healthcare Partners and NEA. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are offered to startups by NEA.
|
Founded Year | Domain | Location | |
|
Venture capital fund backed incubator focused on the healthcare startups
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward healthcare companies by Longwood Fund.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Millendo Therapeutics
Millendo Therapeutics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Alizé Pharma. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Develop drugs, proteins and peptides for the treatment of metabolic and rare diseases
|
2007 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Millendo Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Millendo Therapeutics Comparisons
Competitors of Millendo Therapeutics
Millendo Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BeiGene, Moderna, Incyte, Regeneron Pharmaceuticals and Mereo BioPharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Antibodies are developed for treating cancer, eye, and inflammatory diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
ALX Oncology is focused on advancing cancer treatment therapies.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Millendo Therapeutics
Frequently Asked Questions about Millendo Therapeutics
When was Millendo Therapeutics founded?
Millendo Therapeutics was founded in 2012.
Where is Millendo Therapeutics located?
Millendo Therapeutics is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.
Is Millendo Therapeutics a funded company?
Millendo Therapeutics is a funded company, having raised a total of $102.77M across 5 funding rounds to date. The company's 1st funding round was a Series A of $16M, raised on Apr 23, 2012.
How many employees does Millendo Therapeutics have?
As of Dec 31, 2022, the latest employee count at Millendo Therapeutics is 30.
What does Millendo Therapeutics do?
Millendo Therapeutics was founded in 2012 in Ann Arbor, United States, within the biotechnology sector. Focus is placed on immune-mediated targeted therapies for cancer. The product pipeline is composed of TPST-1120, a PPARα antagonist used in hepatocellular carcinoma, cholangiocarcinoma, and renal cell carcinoma; TPST-1495, applied to multiple solid tumors; and a TREX-1 inhibitor. Operations center on advancing these candidates through clinical development.
Who are the top competitors of Millendo Therapeutics?
Millendo Therapeutics's top competitors include Moderna, BeiGene and Strand Therapeutics.
How many acquisitions has Millendo Therapeutics made?
Millendo Therapeutics has made 1 acquisition, including Alizé Pharma.
Who are Millendo Therapeutics's investors?
Millendo Therapeutics has 10 investors. Key investors include University of Michigan, Frazier Healthcare Partners, NEA, 5AM Ventures, and Renaissance Venture Capital Fund.